Martingale Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Martingale Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-56,919	Closed	-$536K	–	1107
2020 Q3	$536K	Sell	56,919 -2,100	-4%	-$20K	0.01%	795
2020 Q2	$452K	Buy	59,019 +800	+1%	+$6.12K	0.01%	895
2020 Q1	$360K	Buy	58,219 +1,100	+2%	+$9.69K	﹤0.01%	861
2019 Q4	$696K	Buy	57,119 +6,500	+13%	+$71K	0.01%	826
2019 Q3	$585K	Hold	50,619	–	–	0.01%	855
2019 Q2	$506K	Buy	50,619 +4,300	+9%	+$46.4K	0.01%	884
2019 Q1	$597K	Buy	46,319 +11,989	+35%	+$179K	0.01%	860
2018 Q4	$522K	Buy	34,330 +18,895	+122%	+$360K	0.01%	851
2018 Q3	$309K	Buy	+15,435	New	+$351K	﹤0.01%	901
2017 Q1	–	Sell	-13,813	Closed	-$481K	–	1011
2016 Q4	$481K	Buy	+13,813	New	+$413K	0.01%	832

Martingale Asset Management's AMAG Position: Q4 2020 in Review

Martingale Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 56,919 shares — an estimated $536K sold.

Martingale Asset Management first reported a position in AMAG in Q4 2016 and held it in 10 quarters. The position peaked at $696K in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Martingale Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Martingale Asset Management sold 56,919 AMAG Pharmaceuticals shares in Q4 2020, an estimated $536K.
Martingale Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 10 quarters.
Martingale Asset Management's AMAG Pharmaceuticals position peaked at $696K in Q4 2019.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.